Strides completes US$1.75 billion sale of Agila Specialties to Mylan

Date closed: 12/4/2013

Value: US$1.75 billion

On December 4, 2013, Strides Arcolab Ltd completed the sale of its Agila Specialties Pharma Corporation business to Mylan Inc. for a total consideration of up to US$1.75 billion.

Strides Arcolab, headquartered in Bangalore, India, is a global pharmaceutical company.

​BLG acted as Canadian counsel to Strides Arcolab Limited with a team led by Pascal de Guise that included Yaniv Saragosti, Ryan Tomicic, Daniel Urbas and Brian Schneiderman.